These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 2940689

  • 1. Oral plus intramuscular medroxyprogesterone acetate (high dose Farlutal) in advanced breast cancer.
    Ngelangel CA, Jimenez MV, Villalon AH, Agustin BM.
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):634-7. PubMed ID: 2940689
    [Abstract] [Full Text] [Related]

  • 2. Medroxyprogesterone acetate at very high doses in postmenopausal advanced breast cancer patients.
    Pannuti F, Longhi A, Martoni A, Piana E, Baroni M.
    Chemioterapia; 1987 Dec; 6(6):396-8. PubMed ID: 2963702
    [Abstract] [Full Text] [Related]

  • 3. Oral route administration of medroxyprogesterone acetate (MAP) at high doses in the treatment of advanced breast cancer: clinical results.
    Guarnieri A, Tucci E, D'Aniello C, Carli A, Mariani L, De Stefano A, Nardi P.
    Chemioterapia; 1984 Oct; 3(5):320-3. PubMed ID: 6241848
    [Abstract] [Full Text] [Related]

  • 4. [Clinical investigation of oral high-dose medroxyprogesterone acetate (MPA) in advanced breast cancer--double-blind controlled study: Japanese Group for MPA Treatment of Breast Cancer].
    Izuo M, Tominaga T, Yoshida M, Nomura Y, Abe O, Enomoto K, Kubo K, Takatani O.
    Gan No Rinsho; 1985 May; 31(5):487-93. PubMed ID: 3160869
    [Abstract] [Full Text] [Related]

  • 5. [High dose medroxyprogesterone acetate in metastatic breast cancer. Comparative clinical, pharmacokinetic and pharmacodynamic data of different forms of administration].
    Blossey HC, Wander HE, Nagel GA, Köbberling J, Kleeberg U.
    Onkologie; 1982 Aug; 5 Suppl():13-6. PubMed ID: 6215599
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Phase II study of medroxyprogesterone acetate in advanced breast cancer].
    Ueno K, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Nakamura T, Ito Y, Imajo K, Ozeki H.
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3198-202. PubMed ID: 2946264
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Gestagen therapy of breast cancer. Effect of high doses on the blood coagulation system].
    Schenk H, Fereberger W.
    MMW Munch Med Wochenschr; 1983 Oct 07; 125(40):875-6. PubMed ID: 6226871
    [No Abstract] [Full Text] [Related]

  • 15. [The elevation of serum iron level with oral administration of medroxyprogesterone acetate (MPA) in patients with breast cancer].
    Kadota K, Wada T, Watatani M, Houjou T, Mori N, Yasutomi M.
    Gan To Kagaku Ryoho; 1991 May 07; 18(6):983-7. PubMed ID: 1827574
    [Abstract] [Full Text] [Related]

  • 16. [Plasma lipoprotein fractions in high-dose medroxyprogesterone acetate therapy in metastatic breast cancer].
    Brockerhoff P, Grill HJ, Holzer A, Kreienberg R, Pollow K, Schicketanz KH, Schwarz V, Rathgen GH.
    Gynakol Rundsch; 1991 May 07; 31(4):189-200. PubMed ID: 1839014
    [Abstract] [Full Text] [Related]

  • 17. [Results of the treatment of patients with advanced breast with large doses of medroxyprogesterone acetate].
    Zulichowska J, Krawczyk J, Glińska H.
    Pol Tyg Lek; 1988 May 30; 43(22):712-4. PubMed ID: 2976163
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Therapeutic effects of medroxyprogesterone acetate in recurrent or advanced breast cancer].
    Yoshida M, Murai H, Miura S.
    Gan To Kagaku Ryoho; 1985 Mar 30; 12(3 Pt 1):516-23. PubMed ID: 3159345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.